Publicacións en colaboración con investigadores/as de Ben-Gurion University of the Negev (17)

2023

  1. Complications related to the Cook–Swartz implantable Doppler probe use in head and neck microvascular reconstruction: a systematic review

    European Archives of Oto-Rhino-Laryngology, Vol. 280, Núm. 1, pp. 23-37

2020

  1. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study

    The Lancet Gastroenterology and Hepatology, Vol. 5, Núm. 5, pp. 454-464

  2. The use of 5-aminosalicylate for patients with Crohn’s disease in a prospective European inception cohort with 5 years follow-up – an Epi-IBD study

    United European Gastroenterology Journal, Vol. 8, Núm. 8, pp. 949-960

2019

  1. Natural Disease Course of Ulcerative Colitis during the First Five Years of Follow-up in a European Population-based Inception Cohort - An Epi-IBD Study

    Journal of Crohn's and Colitis, Vol. 13, Núm. 2, pp. 198-208

  2. Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: An Epi-IBD study

    Gut, Vol. 68, Núm. 3, pp. 423-433

2018

  1. Cumulative exposure to biological therapy and risk of cancer in patients with psoriasis: a meta-analysis of Psonet studies from Israel, Italy, Spain, the U.K. and Republic of Ireland

    British Journal of Dermatology, Vol. 179, Núm. 4, pp. 863-871

2017

  1. Factors associated with receiving biologics or classic systemic therapy for moderate-to-severe psoriasis: Evidence from the psonet registries

    Acta Dermato-Venereologica

  2. Occurrence of anaemia in the first year of inflammatory bowel disease in a European population-based inception cohort-An ECCO-EpiCom study

    Journal of Crohn's and Colitis, Vol. 11, Núm. 10, pp. 1213-1222

  3. Risk of serious infections, cutaneous bacterial infections, and granulomatous infections in patients with psoriasis treated with anti–tumor necrosis factor agents versus classic therapies: Prospective meta-analysis of Psonet registries

    Journal of the American Academy of Dermatology, Vol. 76, Núm. 2, pp. 299-308.e16

2016

  1. European experience with methotrexate treatment in Crohn's disease: A multicenter retrospective analysis

    European Journal of Gastroenterology and Hepatology, Vol. 28, Núm. 7, pp. 802-806

2014

  1. East-West gradient in the incidence of inflammatory bowel disease in Europe: The ECCO-EpiCom inception cohort

    Gut, Vol. 63, Núm. 4, pp. 588-597

  2. Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe - An ECCO-EpiCom study

    Journal of Crohn's and Colitis, Vol. 8, Núm. 7, pp. 607-616

  3. Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: Results of the 2011 ECCO-EpiCom inception cohort

    Journal of Crohn's and Colitis, Vol. 8, Núm. 11, pp. 1506-1515

  4. Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: The ECCO-EpiCom cohort

    Inflammatory Bowel Diseases, Vol. 20, Núm. 1, pp. 36-46

2013

  1. Systemic psoriasis therapy shows high between-country variation: A sign of unwarranted variation? Cross-sectional analysis of baseline data from the PSONET registries

    British Journal of Dermatology

2012

  1. Challenges for synthesising data in a network of registries for systemic psoriasis therapies

    Dermatology, Vol. 224, Núm. 3, pp. 236-243

  2. Erratum to "Cancer in inflammatory bowel disease 15years after diagnosis in a population-based European Collaborative follow-up study" [J Crohns Colitis (2011) 5, 430-442]

    Journal of Crohn's and Colitis